CTSA K12 Program at the University of Michigan

密歇根大学 CTSA K12 项目

• 批准号: 10621008
• 负责人: VICKI L ELLINGROD
• 金额: $ 162万
• 依托单位: UNIVERSITY OF MICHIGAN AT ANN ARBOR
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-04-01 至 2028-03-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10621008
• 关键词: Acceleration; Address; Advocate; Area; Clinical; Clinical Research; Communities; Competency-Based Education; Educational Curriculum; Evaluation; Extramural Activities; Faculty; Feedback; Funding; Genomics; Health; Human; Influentials; Institution; Lead; Mentored Clinical Scientist Development Program; Mentors; Michigan; Outcome; Paper; Pattern; Pharmaceutical Preparations; Policies; Policy Research; Postdoctoral Fellow; Preparation; Program Development; Research; Research Project Grants; Research Support; Research Training; Science; Scientist; Secure; Social Network; Time; Training; Translational Research; Translations; Universities; Work; career; career development; fortification; health disparity; innovation; multidisciplinary; opioid epidemic; programs; social media; success; translational research program

Project Summary/Abstract The Michigan Institute for Clinical & Health Research (MICHR) career development programs have provided innovative and impactful clinical and translational research training and support to more than 90 diverse multidisciplinary scientists since 2017 who have continued on to make important scientific discoveries. Over the past 15 years our alumni have authored more than 3300 scientific papers that have generated more than 53,000 social media remarks and been included in 240 policy documents. They have also received more than $400M in research grant support. Our scholars have emerged as translational science leaders and influential mentors for those following their path as they lead translational research programs at the national level. Their efforts have contributed to solving some of the nation's most vexing health challenges ranging from basic drug and genomic discovery to policy research addressing health disparities and the opioid crisis. MICHR's K12 program is continually strengthened through our robust evaluation platform, which integrates critical feedback from multiple stakeholder groups to implement new competency-based educational initiatives. Our outstanding program faculty, all of which have undergone mentor training, welcome our K12 scholars into their highly successful research programs (more than $90M in extramural funds). The new MICHR K12 program will support 11 scholars annually, who are at a senior postdoctoral fellow or early faculty level, by providing new programmatic initiatives to support institutional transformation regarding the often invisible but pervasive patterns that disproportionately alter careers for those underrepresented in their fields (i.e., the hidden curriculum). Through the following areas of thematic focus, we will support each K12 scholar for two to three years as they work to gain translational research independence during their time in our program: 1) Fortify career trajectories with precision preparation in translational science and research; 2) Accelerate translation by preparing scholars to best utilize scientific social networks; 3) Prepare scholars to be versatile communicators who lead effective research teams and become science advocates. Our expected outcome is a K12 program that better prepares and equips scholars for long-term successes in conducting translational research and science, particularly after leaving our program as they secure external research support. Moreover, these efforts will motivate change in pervasive patterns that can alter scholars' long-term success as they work to become translational science leaders in their fields. These efforts will also allow us to continue MICHR's legacy of building strong leaders within diverse research scientific communities that impact human health.

项目总结/摘要 密歇根临床与健康研究所（MICHR）职业发展计划提供了 创新和有影响力的临床和转化研究培训和支持90多个不同的 自2017年以来，多学科科学家继续做出重要的科学发现。超过 在过去的15年里，我们的校友已经撰写了3300多篇科学论文，产生了超过 5.3万条社交媒体评论，并被纳入240份政策文件。他们还收到了超过 4亿美元的研究资助。我们的学者已经成为翻译科学的领导者和有影响力的 导师为那些遵循他们的道路，因为他们在国家一级领导翻译研究计划。他们的 这些努力有助于解决美国一些最棘手的健康挑战， 从基因组发现到解决健康差距和阿片类药物危机的政策研究。MICHR的K12 通过我们强大的评估平台，该计划不断得到加强，该平台整合了关键反馈 从多个利益攸关方群体中获得资金，以实施新的基于能力的教育举措。以优异 计划教师，所有这些都经历了导师培训，欢迎我们的K12学者进入他们的高度 成功的研究项目（超过9000万美元的校外资金）。新的MICHR K12计划将 每年支持11名学者，谁是在高级博士后研究员或早期的教师水平，通过提供新的 方案举措，以支持体制转型， 不成比例地改变那些在其领域代表性不足的人的职业生涯的模式（即，隐藏的 课程）。通过以下主题重点领域，我们将支持每个K12学者两到三个 他们在我们的项目期间努力获得翻译研究的独立性：1）加强 在翻译科学和研究中精确准备的职业轨迹; 2）通过以下方式加速翻译 为学者最好地利用科学社交网络做好准备; 3）为学者成为多才多艺的传播者做好准备 他们领导着高效的研究团队，成为科学的倡导者。我们的预期结果是K12计划 更好地准备和装备学者进行翻译研究的长期成功， 科学，特别是在离开我们的计划，因为他们获得外部研究支持。而且这些 这些努力将推动普遍模式的改变，这些模式可以改变学者的长期成功， 成为各自领域的转化科学领导者。这些努力也将使我们能够继续人权专员办事处的遗产 在影响人类健康的不同研究科学界建立强有力的领导者。